España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Oppenheimer & Co.
AI Will Drive 25% Of GDP In 10 Years, Says Analyst: Which Company Will Emerge The Winner?
MindMed's Shares Drop 50% On $30M Public Offering
Leafly Cannabis Info Platform Goes Public Via Deal With Merida Merger Corp, The Combined Company Equity Projected At $532M
MindMed's Shares Drop 50% On $30M Public Offering
Leafly Cannabis Info Platform Goes Public Via Deal With Merida Merger Corp, The Combined Company Equity Projected At $532M
Oppenheimer NAREIT Preview: A Bullish Outlook On Real Estate
Oppenheimer: 25% Upside For Small-Cap REIT Bluerock Residential
Oppenheimer NAREIT Preview: A Bullish Outlook On Real Estate
|
Oppenheimer: 25% Upside For Small-Cap REIT Bluerock Residential
|
Solid Q1 For Morgan Stanley, But Oppenheimer Says Not Big Enough To Move The Needle
|
Oppenheimer And Zillow: Model Adjusted Amid Trulia Acquisition, Shares Rebounding
|
Read More...
Oppenheimer & Co. Recent News
UPDATE: Oppenheimer Raises Price Target On Chipotle Mexican Grill, Inc.
|
U.S. Oil Refining Eyes Big Expansion Amid Shale Spike
|
Do Recent J.C. Penney Share Prices Reflect Investor Optimism or False Hope?
|
UPDATE: Oppenheimer Initiates Fusion-io at Perform Rating on Current Competitive Advantage
|
Oppenheimer Maintains Corning at Outperform on Long-Term Segment Display Positivity
|
UPDATE: Oppenheimer Raises Gilead PT on Promising Oncology Pipeline
|
UPDATE: Oppenheimer Raises Semtech PT to $41 Following Gennum Acquisition
|
Oppenheimer Maintains Outperform on Nvidia
|
Oppenheimer Maintains Outperform on Apple
|
UPDATE: Oppenheimer Upgrades Linear Technology to Outperform, Establishes $36 PT
|
Oppenheimer Has Perform on RRsat Global Communications Networks
|
Oppenheimer Outperform on Netease.com
|
Oppenheimer Has Perform on NetApp
|
Oppenheimer Has Perform on Vistaprint
|
Oppenheimer Has Perform on Simcere Pharmaceutical Group
|
Oppenheimer Outperform on AEterna Zentaris
|
Oppenheimer Outperform on Mindray Medical
|
Oppenheimer Outperform on Kodiak Oil & Gas
|
Oppenheimer Outperform on Globe Specialty Metals
|
Oppenheimer Outperform on MedAssets
|
Oppenheimer Outperform on Amedisys
|
Oppenheimer Outperform on Generac
|
UPDATE: Oppenheimer Lowering Price Target on OpenTable
|